HK1000311A1 - Hepatobiliary nmr contrast agents - Google Patents

Hepatobiliary nmr contrast agents

Info

Publication number
HK1000311A1
HK1000311A1 HK97101880A HK97101880A HK1000311A1 HK 1000311 A1 HK1000311 A1 HK 1000311A1 HK 97101880 A HK97101880 A HK 97101880A HK 97101880 A HK97101880 A HK 97101880A HK 1000311 A1 HK1000311 A1 HK 1000311A1
Authority
HK
Hong Kong
Prior art keywords
nmr
hepatobiliary
contrast agents
relaxivity
contrast agent
Prior art date
Application number
HK97101880A
Other languages
English (en)
Inventor
Randall B Lauffer
Thomas J Brady
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24941167&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1000311(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of HK1000311A1 publication Critical patent/HK1000311A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Steroid Compounds (AREA)
HK97101880A 1985-05-08 1997-10-04 Hepatobiliary nmr contrast agents HK1000311A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/731,841 US4899755A (en) 1985-05-08 1985-05-08 Hepatobiliary NMR contrast agents
PCT/US1986/001035 WO1986006605A1 (fr) 1985-05-08 1986-05-08 Agents de contraste hepatobiliaire pour resonance magnetique nucleaure

Publications (1)

Publication Number Publication Date
HK1000311A1 true HK1000311A1 (en) 1998-02-27

Family

ID=24941167

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97101880A HK1000311A1 (en) 1985-05-08 1997-10-04 Hepatobiliary nmr contrast agents

Country Status (11)

Country Link
US (1) US4899755A (fr)
EP (2) EP0222886B2 (fr)
JP (3) JPH0819005B2 (fr)
AT (1) ATE143241T1 (fr)
CA (1) CA1264663A (fr)
DE (2) DE122005000008I2 (fr)
HK (1) HK1000311A1 (fr)
LV (1) LV11981B (fr)
NL (1) NL300177I2 (fr)
SG (1) SG43886A1 (fr)
WO (1) WO1986006605A1 (fr)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5186922A (en) * 1985-03-15 1993-02-16 See/Shell Biotechnology, Inc. Use of biodegradable microspheres labeled with imaging energy constrast materials
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
MX174467B (es) * 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
GB8603537D0 (en) * 1986-02-13 1986-03-19 Parker D Conjugate compound
US5342607A (en) * 1986-07-03 1994-08-30 Advanced Magnetics, Inc. Receptor mediated endocytosis type magnetic resonance imaging contrast agents
US5284646A (en) * 1986-07-03 1994-02-08 Advanced Magnetics Inc. Hepatocyte specific receptor mediated endocytosis type magnetic resonance imaging contrast agents
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
US5352432A (en) * 1986-07-03 1994-10-04 Advanced Magnetics, Inc. Hepatocyte specific composition and their use as diagnostic imaging agents
US5399340A (en) * 1987-09-24 1995-03-21 Schering Aktiengesellschaft Use of amide complex compounds
DE68926708T2 (de) 1988-08-04 1996-10-31 Advanced Magnetics Inc Von einem rezeptor induziertes kontrastmittel für den endocytose-typ mri
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5599923A (en) * 1989-03-06 1997-02-04 Board Of Regents, University Of Tx Texaphyrin metal complexes having improved functionalization
US5252720A (en) * 1989-03-06 1993-10-12 Board Of Regents, The University Of Texas System Metal complexes of water soluble texaphyrins
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis
US5162509A (en) * 1989-03-06 1992-11-10 Board Of Regents, The University Of Texas System Process for preparing expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5567687A (en) * 1989-03-06 1996-10-22 University Of Texas Texaphyrins and uses thereof
US5808003A (en) * 1989-05-26 1998-09-15 Perimmune Holdings, Inc. Polyaminocarboxylate chelators
US5292868A (en) * 1989-05-26 1994-03-08 Akzo N.V. Chelating agents for attaching metal ions to proteins
AU638757B2 (en) * 1989-05-26 1993-07-08 Akzo N.V. Chelating agents for attaching metal ions to proteins
US6039931A (en) * 1989-06-30 2000-03-21 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
US5695739A (en) * 1989-06-30 1997-12-09 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
CA2065290C (fr) * 1989-08-28 2000-12-12 Randall B. Lauffer Chelates de metal et de composes du type hydroxy-aryle utiles pour l'imagerie rmn diagnostique
US5594136A (en) * 1989-12-21 1997-01-14 Pharmacyclics, Inc. Texaphyrin solid supports and devices
GB9001245D0 (en) * 1990-01-19 1990-03-21 Salutar Inc Compounds
JP3131219B2 (ja) * 1990-01-19 2001-01-31 ニユコメド・イメージング・アクシエセルカペト キレート化合物
US5124471A (en) * 1990-03-26 1992-06-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bifunctional dtpa-type ligand
GB9007408D0 (en) * 1990-04-02 1990-05-30 Nycomed As Compositions
JPH04154729A (ja) * 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
US5169944A (en) * 1991-04-12 1992-12-08 Board Of Regents Of The University Of Washington Methods and compositions for the enteral administration of hepatobiliary MRI contrast agents
US6875864B2 (en) 1991-08-01 2005-04-05 Bracco International B.V. Aminocarboxylate ligands having substituted aromatic amide moieties
US5562894A (en) * 1991-08-09 1996-10-08 Regents Of The University Of California Amino-acyl-type and catecholamine-type contrast agents for MRI
GB9120508D0 (en) * 1991-09-26 1991-11-06 Nycomed As Diagnostic agents
US5888997A (en) * 1994-04-14 1999-03-30 Pharmacyclics, Inc. Radiation sensitization using texaphyrins
US5565552A (en) * 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5763172A (en) * 1992-01-21 1998-06-09 Board Of Regents, The University Of Texas System Method of phosphate ester hydrolysis
US5607924A (en) * 1992-01-21 1997-03-04 Pharmacyclics, Inc. DNA photocleavage using texaphyrins
US5595726A (en) * 1992-01-21 1997-01-21 Pharmacyclics, Inc. Chromophore probe for detection of nucleic acid
US5462725A (en) * 1993-05-06 1995-10-31 The Dow Chemical Company 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
US5385893A (en) * 1993-05-06 1995-01-31 The Dow Chemical Company Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
US5798491A (en) * 1993-06-09 1998-08-25 Board Of Regents, The University Of Texas System Multi-mechanistic chemical cleavage using certain metal complexes
GB9314499D0 (en) * 1993-07-12 1993-08-25 Nycomed Imaging As Method
US5358704A (en) * 1993-09-30 1994-10-25 Bristol-Myers Squibb Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents
JP3878208B2 (ja) * 1994-04-08 2007-02-07 ブラッコ インターナショナル ベスローテン フェンノートシャップ 芳香族アミド化合物およびそれらのキレート
US5476644A (en) * 1994-04-13 1995-12-19 Sterling Winthrop Inc. Cyclic triamine chelating agents
US5969111A (en) * 1994-04-14 1999-10-19 Board Of Regents, The University Of Texas System Texaphyrins substituted with imidazole are provided
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US6693190B1 (en) 1994-05-11 2004-02-17 Bracco International B.V. Enhanced relaxivity monomeric and multimeric compounds
US5633354A (en) * 1994-09-21 1997-05-27 Pharmacyclics, Inc. Phosphoramidite derivatives of texaphyrins
US5837866A (en) * 1994-09-21 1998-11-17 Board Of Regents, The University Of Texas Phosphoramidite derivatives of macrocycles
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
TW319763B (fr) 1995-02-01 1997-11-11 Epix Medical Inc
US5756726A (en) * 1995-06-02 1998-05-26 Pharmacyclics, Inc. Methods of producing singlet oxygen using compounds having improved functionalization
US5714328A (en) * 1995-06-07 1998-02-03 Board Of Regents, The University Of Texas System RNA photocleavage using texaphyrins
ES2217408T3 (es) 1996-04-01 2004-11-01 Epix Medical, Inc. Agentes diagnosticos de contraste para formacion de imagenes bioactivados.
DE19641197C2 (de) * 1996-09-24 1999-02-18 Schering Ag Ionenpaare und ihre Verwendung als Kontrastmittel
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
US6495118B1 (en) 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
EP1031354A3 (fr) 1999-01-19 2003-02-05 Rohm And Haas Company Agents de contraste polymère pour imagerie RMN
US7311893B2 (en) * 2000-07-25 2007-12-25 Neurochem (International) Limited Amyloid targeting imaging agents and uses thereof
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) * 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
JP2006514915A (ja) 2002-03-01 2006-05-18 ダイアックス、コープ Ｋｄｒおよびｖｅｇｆ／ｋｄｒ結合ペプチドならびに診断および治療におけるその使用
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
WO2004065621A1 (fr) 2002-03-01 2004-08-05 Dyax Corp. Peptides de liaison kdr et vegf/kdr et leur utilisation a des fins diagnostiques et therapeutiques
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7303741B2 (en) * 2002-09-23 2007-12-04 General Electric Company Systems and methods for high-resolution in vivo imaging of biochemical activity in a living organism
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
EP1603935A4 (fr) 2003-03-03 2007-03-21 Dyax Corp PEPTIDES PRESENTANT UNE FIXATION SPECIFIQUE AVEC LE RECEPTEUR DE HGF (cMET) ET SES UTILISATIONS
BRPI0410635A (pt) 2003-05-23 2006-06-13 Epix Pharm Inc isÈmeros enriquecidos e opticamente puros de ligantes de quelação e agentes de contraste
BRPI0412824A (pt) * 2003-07-24 2006-09-26 Bracco Imaging Spa composições radiofarmacêuticas estáveis e métodos para suas preparações
WO2006084257A2 (fr) * 2005-02-03 2006-08-10 Epix Pharmaceuticals, Inc. Methodes de perfusion a l'etat stationnaire
JP2009274962A (ja) * 2008-05-12 2009-11-26 Yoshihiro Ishikawa 鉄サレン錯体、磁性を有する薬剤、薬剤の誘導システム、並びに磁気検出装置
US20120045393A1 (en) 2009-03-17 2012-02-23 Linder Karen E Lhrh-ii peptide analogs
WO2010121133A2 (fr) 2009-04-17 2010-10-21 The General Hospital Corporation Imagerie multimodale de fibrine
BRPI1009900A2 (pt) 2009-03-19 2016-03-15 Wyeth Llc métodos para a preparação de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfônico e seus precursores
US8378134B2 (en) * 2009-09-30 2013-02-19 General Electric Company Hydroxylated contrast enhancement agents
US20110077417A1 (en) * 2009-09-30 2011-03-31 General Electric Company Intermediates for Hydroxylated Contrast Enhancement Agents
US20110077396A1 (en) * 2009-09-30 2011-03-31 General Electric Company Intermediates for hydroxylated contrast enhancement agents
US8722020B2 (en) * 2010-03-31 2014-05-13 General Electric Company Hydroxylated contrast enhancement agents
WO2015038968A1 (fr) 2013-09-13 2015-03-19 The General Hospital Corporation Sondes de liaison à la fibrine activables
JP5806356B2 (ja) * 2014-03-10 2015-11-10 株式会社Ihi 鉄サレン錯体、磁性を有する薬剤、薬剤の誘導システム、並びに磁気検出装置
WO2015171543A1 (fr) 2014-05-05 2015-11-12 California Institute Of Technology Agents de capture mutants spécifiques d'akt, compositions et procédés d'utilisation et de préparation associés
WO2015196208A2 (fr) 2014-06-20 2015-12-23 The General Hospital Corporation Sondes d'imagerie ciblées sur le collagène
EP3270951B1 (fr) 2015-03-16 2020-09-09 California Institute of Technology Agents de capture spécifiques de la neurotoxine botulique, compositions et méthodes d'utilisation et de préparation associées
WO2017011769A2 (fr) 2015-07-15 2017-01-19 California Institute Of Technology Agents de capture spécifiques d'il-17f, compositions et procédés d'utilisation et de production
JP2018523671A (ja) 2015-08-13 2018-08-23 ザ ジェネラル ホスピタル コーポレイション 分子ｍｒイメージング用マンガン系キレートコンジュゲート
CN115109120A (zh) 2016-04-04 2022-09-27 英蒂分子公司 Cd8-特异性捕获剂、组合物及使用和制备方法
WO2018064597A1 (fr) 2016-09-29 2018-04-05 Indi Molecular, Inc. Compositions pour la détection, l'inhibition et l'imagerie de l'indoléamine 2,3-dioxygénase 1 (ido1) et leurs méthodes de production et d'utilisation
WO2018085375A1 (fr) 2016-11-01 2018-05-11 Ohio State Innovation Foundation Procédés d'iodation de biomolécules
US11719705B2 (en) 2017-06-15 2023-08-08 Indi Molecular, Inc. IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making
US11919972B2 (en) 2018-11-02 2024-03-05 Regeneron Pharmaceuticals, Inc. Peptide libraries with non-canonical amino acids
WO2020097531A1 (fr) 2018-11-08 2020-05-14 Indi Molecular, Inc. Agents de capture théranostiques, compositions et procédés d'utilisation et de fabrication
US20200291391A1 (en) 2019-03-12 2020-09-17 Indi Molecular, Inc. Cross-linked epitopes and methods of use thereof
US20200371101A1 (en) 2019-05-20 2020-11-26 Indi Molecular, Inc. Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (ido1)
US11414460B2 (en) 2019-07-19 2022-08-16 Institute For Systems Biology KRAS-specific capture agents, compositions, and methods of making and using
EP4143227A2 (fr) 2020-04-30 2023-03-08 Sairopa B.V. Anticorps anti-cd103
WO2022098743A1 (fr) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, imagerie et procédés thérapeutiques ciblant le récepteur 1 de folate (folr1)
WO2022098745A1 (fr) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, systèmes d'administration et méthodes utiles dans la thérapie antitumorale

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088747A (en) * 1975-02-19 1978-05-09 Australian Atomic Energy Commission Phenolic amino-carboxylic acid radiopharmaceuticals
US4150047A (en) * 1978-03-06 1979-04-17 Air Products And Chemicals, Inc. Process for preparing halogenated metal chelates
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
US4308249A (en) * 1979-12-13 1981-12-29 G. D. Searle & Co. Radiopharmaceutical complexes of N-(tri-substituted alkyl)-iminodiacetic acids
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4401647A (en) * 1980-03-03 1983-08-30 The Regents Of The University Of Ca Radiolabeled neoglycopeptides
US4361544A (en) * 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
FR2550449B1 (fr) * 1983-08-12 1986-01-31 Commissariat Energie Atomique Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents

Also Published As

Publication number Publication date
LV11981A (lv) 1998-03-20
JP2002220348A (ja) 2002-08-09
DE3650572T3 (de) 2006-06-29
NL300177I2 (nl) 2005-08-01
DE3650572T2 (de) 1997-04-17
SG43886A1 (en) 1997-11-14
DE3650572D1 (de) 1996-10-31
ATE143241T1 (de) 1996-10-15
WO1986006605A1 (fr) 1986-11-20
JPH10152447A (ja) 1998-06-09
US4899755A (en) 1990-02-13
DE122005000008I1 (de) 2005-05-25
JPH0819005B2 (ja) 1996-02-28
CA1264663A (fr) 1990-01-23
EP0222886B2 (fr) 2002-05-02
EP0222886A1 (fr) 1987-05-27
EP0222886A4 (fr) 1988-07-04
EP0722739A1 (fr) 1996-07-24
JPS62503034A (ja) 1987-12-03
LV11981B (en) 1998-06-20
DE122005000008I2 (de) 2006-02-02
EP0222886B1 (fr) 1996-09-25
NL300177I1 (nl) 2005-05-02

Similar Documents

Publication Publication Date Title
HK1000311A1 (en) Hepatobiliary nmr contrast agents
EP0727224A3 (fr) Agents diagnostiques
ES8603758A1 (es) Procedimiento para la obtencion de un complejo lantanido pa-ramagnetico de efecto modificador del contraste de una ima- gen medica por rmn.
HK18094A (en) Use of ferromagnetic particles in contrast agents for nmr imaging and contrast agents
ATE99544T1 (de) Liposomale radiologische kontrastmittel.
ATE63826T1 (de) Pumpenkoerper zum anschluss einer bestrahlungskammer an ein system zur behandlung eines patienten durch photoaktivierung.
SG46496A1 (en) Tricyclopolyazamacrocyclophosphonic acids complexes and derivatives thereof for use as constrast agents
GB2307178A (en) Magnetotherapy device
DE3854717D1 (de) Verfahren zur erhöhung der sicherheit von metall-ligandchelaten als röntgenstrahlen-kontrastmittel.
JPS5649156A (en) Circulating or pump feeding method for living body liquid* particularly* blood and its device
ES2117670T3 (es) Derivado de hidroxamato e hidrazida de poliaminas y su uso medico como agentes quelantes.
ATE106751T1 (de) Mittel für magnetische resonanzbilderzeugung.
WO1991015466A3 (fr) Agents chelateurs
DE69732370D1 (de) Spinresonanz kontrastmittel für das blut
Bryant Estimation of human exposure to the carcinogenic aromatic amine 4-aminobiphenyl via hemoglobin dosimetry
HU905295D0 (en) Process for the treating and eliminating of functional disorders occurring in the tissues, in the heart or in other organs showing strong bioelectrical activity by using magnetic space
NO904337L (no) Kontrastmidler for magnetisk resonansavbildning.
SU1823177A1 (ru) Способ подготовки сосудистых ксенопротезов и клапанов сердца к имплантации
ES288516U (es) Dispositivo de efectos terapeuticos aplicable en personas
DE3786442T2 (de) Verwendung von Follikelreifungshormon zur Herstellung eines therapeutischen Mittels zur Behandlung von Neoplasmen von gonadalem Ursprung.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20060507